Rivaroxaban Versus Warfarin for the Treatment of Cerebral Venous Thrombosis (RWCVT): A Randomized Controlled Trial in Resource-Limited Setting
Trial Registration: ClinicalTrials.gov identifier: NCT04569279
Saved in:
| Main Authors: | Ahmad Alkhawam, Lina Okar, Ibrahem Hanafi, Peyton Murin, Ali Ibrahim, Juman Isstaif, Eman Khashaneh, Rami Z. Morsi, Tareq Kass-Hout |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Stroke Research and Treatment |
| Online Access: | http://dx.doi.org/10.1155/srat/8893742 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of Enoxaparin and Rivaroxaban in the Prophylaxis of Deep Venous Thrombosis in Arthroplasty
by: Necati Çiçek, et al.
Published: (2021-01-01) -
The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01) -
Assessing the Comparative Efficacy and Safety of Warfarin and Rivaroxaban for Cancer Associated Thrombosis: Experience From a Resource Limited Setting
by: Abel Tenaw Tasamma, et al.
Published: (2025-01-01) -
Pediatric Posttraumatic Cerebral Venous Sinus Thrombosis: Successful Resolution With Rivaroxaban
by: Yuxuan Zhang, et al.
Published: (2025-01-01) -
Appropriate target range of INR and predictive factors of recurrent thrombosis and bleeding in patients with venous thromboembolism on warfarin
by: Peerasit Sae-Lim, et al.
Published: (2025-07-01)